je.st
news
Aetna picks Gilead Sciences hepatitis C drugs over AbbVie's
2015-01-16 23:38:16| Biotech - Topix.net
Insurer Aetna has made new hepatitis C drugs from Gilead Sciences Inc. preferred treatments for customers with the liver-destroying virus. Aetna Inc. says it's reached a deal with Gilead bringing discounts for Sovaldi and Harvoni, which have list prices of about $84,000 and $94,000, respectively, for a course of treatment.
Tags: sciences
drugs
picks
hepatitis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||